TABLE 5.
ANOVA results from repeat study comparing mean log10 titers between laboratories within visits
| Visit (overall P value for lab effect on GMT) | Labs compared | Estimated difference in log10 titer scalea | 95% CI for difference in mean log10 titera |
|---|---|---|---|
| Prevaccination (0.0246) | Chiron vs MC HPA | 0.005 (1.01) | −0.087, 0.097 (0.82, 1.25) |
| NZ ESR vs MC HPA | 0.048 (1.12) | −0.045, 0.140 (0.90, 1.38) | |
| NIPH vs MC HPA | 0.024 (1.06) | −0.068, 0.116 (0.86, 1.31) | |
| Post-first dose (0.0080) | Chiron vs MC HPA | 0.081 (1.21) | −0.004, 0.167 (0.99, 1.47) |
| NZ ESR vs MC HPA | 0.029 (1.07) | −0.057, 0.114 (0.88, 1.30) | |
| NIPH vs MC HPA | 0.014 (1.03) | −0.071, 0.100 (0.85, 1.26) | |
| Post-second dose (0.1417) | Chiron vs MC HPA | 0.050 (1.12) | −0.040, 0.141 (0.91, 1.38) |
| NZ ESR vs MC HPA | 0.015 (1.04) | −0.076, 0.106 (0.84, 1.28) | |
| NIPH vs MC HPA | 0.008 (1.02) | −0.083, 0.098 (0.83, 1.25) | |
| Post-third dose (0.0025) | Chiron vs MC HPA | 0.176 (1.50) | 0.036, 0.315* (1.09, 2.07) |
| NZ ESR vs MC HPA | −0.019 (0.96) | −0.158, 0.120 (0.70, 1.32) | |
| NIPH vs MC HPA | 0.047 (1.11) | −0.092, 0.186 (0.81, 1.53) |
a
Titer scale values calculated from nonrounded log10 titer values. Values in parentheses show the 95% confidence interval transformed to the titer scale. *, significance at 5% level.